Quest DiagnosticsDGX
NYSEMedical Laboratories
No cached AI snapshot yet for DGX.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
57,000 employees111.00M shares outstandinglisted 1996-12-17dividend yield 1.76%
Next earnings ~Aug 3, 2026 · Ex-dividend Apr 6, 2026 · Dividend $0.86 quarterly
About Quest Diagnostics
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Latest News
Showing market-wide stock news
Dollar hovers around two-month high as Iran-Israel truce hangs in balance
Asia stocks make tentative bounce, bonds pressured
The stock market just got crushed. Why Citi is raising its S&P 500 target.
Franklin Templeton flags critical dividend turning point
A Closer Look At Full-Time And Part-Time Employment: May 2026
How Low Can Bitcoin Go?
Related Stocksin Medical Laboratories
Ready to see the live AI view on DGX?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing DGX side-by-side with live signals.